Articles

Research Correspondence

10.4244/EIJ-D-24-00918 Jun 2, 2025
Biodegradable-polymer versus durable-polymer drug-eluting stents in left main percutaneous coronary intervention: final results of the randomised IDEAL-LM trial
Griffioen A, van Geuns R, McEntegart M, Merkulov E, Krestyaninov O, Kretov E, Lesiak M, O’Kane P, Hanratty C, Bressollette E, Silvestri M, Wlodarczak A, Barragan P, Anderson R, Protopopov A, Peace A, Menown I, Rocchiccioli P, Onuma Y, Oldroyd K

Trial Design

10.4244/EIJ-D-24-01085 Jun 2, 2025
Design and rationale of PRAGUE-26: a multicentre, randomised trial of catheter-directed thrombolysis for intermediate-high risk acute pulmonary embolism
Kroupa J, Radvan M, Mrozek J, Sluka M, Jirous S, Hlinomaz O, Pliva M, Pudil J, Voberkova H, Kozel M, Poloczek M, Kamenik M, Brabec M, Lichnerova E, Hutyra M, Bernat I, Novak M, Tousek P, Kocka V
open access

Flashlight

10.4244/EIJ-D-24-01058 Jun 2, 2025
AMAC: Anchor the Mother to Advance the Child – a technique for complex PCI
Cocco N, Leibundgut G, Spanò A, Weilennmann D, Mashayekhi K

Editorial

10.4244/EIJ-E-25-00018 Jun 2, 2025
Using pericoronary fat attenuation to guide management after coronary interventions
Antoniades C, Chan K
free

Editorial

10.4244/EIJ-E-25-00014 Jun 2, 2025
Polymer-free biolimus-eluting stents: there is no such thing as a free lunch
Piccolo R, Spitzer E
free

Expert consensus

10.4244/EIJ-D-24-00954 Jun 2, 2025
A new implanter classification system for left atrial appendage closure from the European Left Atrial Appendage Closure Club (ELAACC)
Nielsen-Kudsk J, Aminian A, Backer O, Iriart X, Berti S, Galea R, Freixa X, Räber L, Cruz-González I, Wunderlich N, Garot P
free

Original Research

10.4244/EIJ-D-24-00971 Jun 2, 2025
Impact of pericoronary adipose tissue attenuation on clinical outcomes after percutaneous coronary intervention
Naniwa S, Kawamori H, Toba T, Hiromasa T, Sugizaki Y, Sasaki S, Fujii H, Hamana T, Osumi Y, Yamamoto T, Iwane S, Sakamoto Y, Matsuhama K, Fukuishi Y, Tsunamoto H, Higuchi K, Okamoto H, Iwasaki M, Takaya T, Yamada S, Hirata K, Otake H

Original Research

10.4244/EIJ-D-24-00586 Jun 2, 2025
Five-year outcomes of a drug-coated polymer-free biolimus-eluting stent versus an ultrathin-strut biodegradable-polymer sirolimus-eluting stent
Jensen L, Jakobsen L, Eftekhari A, Ellert-Gregersen J, Støttrup N, Engstrøm T, Kahlert J, Freeman P, Veien K, Jensen R, Lassen J, Junker A, Christiansen E

Original Research

10.4244/EIJ-D-24-00763 Jun 2, 2025
Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: five-year results of the randomised, non-inferiority SORT OUT VIII trial
Støttrup N, Christiansen E, Raungaard B, Kahlert J, Terkelsen C, Kristensen S, Thim T, Jakobsen L, Jensen R, Eftekhari A, Freeman P, Jensen S, Veien K, Jensen L, Maeng M, for Randomized Trials with Clinical Outcome (SORT OUT) ftSO

Editorial

10.4244/EIJ-E-25-00023 May 21, 2025
DAPT de-escalation post-ACS: a new rule or just a new option? Lessons from the 4D-ACS trial
Cuisset T, Cayla G
free

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y, Park S-D, Lee JP, Choi SH, Kong MG, Won YS, Kim M, Lee KH, Han SH, Kwon SW, Suh J, Kang WC
open access

Research Correspondence

10.4244/EIJ-D-25-00396 May 21, 2025
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I study
Haude M, Wlodarczak A, van der Schaaf R, Torzewski J, Ferdinande B, Escaned J, Iglesias J, Bennett J, Toth G, Joner M, Toelg R, Wiemer M, Olivecrona G, Vermeersch P, Waksman R

Research Correspondence

10.4244/EIJ-D-24-01048 May 21, 2025
Next-day and 48-hour discharge following alternative access for transcatheter aortic valve implantation
Zendo Y, Ordoñez S, Chu M, Valdis M, Molloy S, Abbadi M, Teefy P, Diamantouros P, Bagur R
Receive our newsletter


The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved